BMPR1A

5 papers study it1 finding

HGNC NCBI Gene Taxon

1 lab in 1 country

Human trial1
Humans1
Animals1
Cells2

Interventions

1

Liraglutide

upin humans1

1 study

Liraglutide increases BMPR1A in humans.
“its inhibitor WFIKKN2, alongside TGF-β receptor BMPR1a were upregulated”
Human trial3.0 mg/day5 weeks
OR09-07 Dynamic Proteomic Profiling in a 5-week Crossover Trial of Liraglutide in Obesity Reveals Weight-Dependent Myostatin Downregulation and Multi-Pathway Effects Beyond Weight Reduction
ENDO 2025 abstractOct 22, 2025

More on Liraglutide

Latest

ENDO 2025 AbstractOct 23

OR09-07 Dynamic Proteomic Profiling in a 5-week Crossover Trial of Liraglutide in Obesity Reveals Weight-Dependent Myostatin Downregulation and Multi-Pathway Effects Beyond Weight Reduction

Randomized trial in 20 peopleLiraglutide

Scientific ReportsDec 1

Application of human platelet lysate in chondrocyte expansion promotes chondrogenic phenotype and slows senescence progression via BMP-TAK1-p38 pathway

Experiments in human cellsInterventions

EBioMedicineSep 14

Genetic landscape of a large cohort of Primary Ovarian Insufficiency: New genes and pathways and implications for personalized medicine

Cohort study of 375 peopleReproductive system

Osteoarthritis and CartilageMar 16

Expression of TGFβ-family signalling components in ageing cartilage: age-related loss of TGFβ and BMP receptors

Experiments in cellsBones and joints

The American Journal of PathologyMay 6

Neonatal hyperoxia causes pulmonary vascular disease and shortens life span in aging mice

Experiments in 100 miceLung